Your browser doesn't support javascript.
loading
Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials.
Sridhar, Vikas S; Neuen, Brendon L; Fletcher, Robert A; Slee, April; Ang, Fernando G; Rapattoni, Wally; Arnott, Clare; Cherney, David Z; Perkovic, Vlado; Wheeler, David C; Levin, Adeera.
Afiliação
  • Sridhar VS; Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Neuen BL; Department of Medicine, Division of Nephrology, University Health Network, Toronto, Ontario, Canada.
  • Fletcher RA; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Slee A; The George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia.
  • Ang FG; Royal North Shore Hospital, Sydney, New South Wales, Australia.
  • Rapattoni W; The George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia.
  • Arnott C; New Arch Consulting, Seattle, Washington, USA.
  • Cherney DZ; Janssen, Inc., Toronto, Ontario, Canada.
  • Perkovic V; Janssen, Inc., Toronto, Ontario, Canada.
  • Wheeler DC; Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
  • Levin A; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
Diabetes Obes Metab ; 25(8): 2331-2339, 2023 08.
Article em En | MEDLINE | ID: mdl-37184050
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article